What is Citius Pharmaceuticals Inc?
, a biopharmaceutical company, focuses on the development and commercialization of critical care products.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 13.96M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.